Phase II
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects with Obesity or Overweight
- Study HIC#:2000039283
- Last Updated:10/02/2025
This is a treatment study of a medication that may help people reduce or stop their drinking and lose weight.
The study provides a medical evaluation, blood tests, brief counseling, and monitoring of your drinking and weight. The study lasts approximately 6 months.
Contact Us
For more information about this study, including how to volunteer, contact:
Susan Neveu
- Phone Number: 1-475-375-7356
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Eligibility Criteria
You may be eligible to participate in this research study if you are:
- Age 18-75
- Overweight
- Want to either reduce your alcohol use or quit drinking alcohol
You will be paid up to $750 for your participation.
